Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
jCyte
AddedFeb 16, 2024
UpdatedJun 18, 2026
jCyte

jCyte

Series A

US-based jCyte pioneers in progenitor cell technology for retinal diseases, offering non-surgical jCell treatment.

HQ
Newport Beach, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in Newport Beach, United States, jCyte is a clinical-stage company dedicated to developing innovative therapies for degenerative retinal disorders. Its core mission is to leverage progenitor cell-based technology to treat retinal diseases, aiming to restore vision and improve quality of life for patients. The company's flagship product, jCell, is a non-surgical, allogeneic treatment delivered via intravitreal injection, currently in late-stage clinical development for retinitis pigmentosa and other inherited retinal conditions.

Notable affiliated individuals include leading ophthalmologists and researchers in the field of retinal diseases. jCyte has attracted significant investment from prominent venture capital firms and biotech investors. Key achievements include successful progression through early clinical trials and recognition within the medical community for its pioneering approach. The company’s impact lies in its potential to offer a groundbreaking treatment option for patients with blinding retinal disorders, positioning itself as a leader in ophthalmic regenerative medicine.

jCyte - Similar Companies

EyeCyte logo

EyeCyte

eyecyte.com

ViaCyte logo

ViaCyte

Celularity logo

Celularity

celularity.com

RhinoCyte logo

RhinoCyte

rhinocyte.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

PharmaCyte Biotech logo

PharmaCyte Biotech

pharmacyte.com

CyThera logo

CyThera

NeuCyte logo

NeuCyte

neucyte.com

HebeCell logo

HebeCell

hebecellcorp.com

Spheringenics logo

Spheringenics

Lineage Cell Therapeutics logo

Lineage Cell Therapeutics

lineagecell.com

CyteQuest logo

CyteQuest

cytequest.com

SymbioCellTech logo

SymbioCellTech

symbiocelltech.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

Stemcyte logo

Stemcyte

stemcyte.com

jCyte - Quick Facts

Who are jCyte's competitors?

Companies similar to jCyte include EyeCyte, ViaCyte, Celularity and RhinoCyte.

When was jCyte founded?

jCyte was founded in 2012.

Where is jCyte's headquarters located?

jCyte's headquarters is located in Newport Beach, CA, US.

When was jCyte's last funding round?

jCyte's most recent funding round was for $3.9M (USD) in March 2019.

How much has jCyte raised to-date?

As of Mar 15, 2019, jCyte has raised a total of $3.9M (USD).

How many employees does jCyte have?

jCyte has 11 employees as of Feb 5, 2024.

jCyte - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapy
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified